These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6420629)

  • 1. Quasi-morphine withdrawal behaviour: indication for a specific involvement of the GABA-ergic nerve terminal compartment.
    van der Laan JW
    Life Sci; 1983; 33 Suppl 1():389-92. PubMed ID: 6420629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
    van der Laan JW; Weick G; van Bleek G
    Biochem Pharmacol; 1985 Nov; 34(21):3789-94. PubMed ID: 3933514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat.
    de Boer T; Bartels K; Metselaar HJ; Bruinvels J
    Psychopharmacology (Berl); 1980; 71(3):257-67. PubMed ID: 6779333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual role for GABA in quasi-morphine abstinence behavior induced by di-n-propylacetate involving both initiation and termination.
    Van der Laan JW; Bruinvels J
    Psychopharmacology (Berl); 1981; 74(2):143-8. PubMed ID: 6791219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of GABA in morphine abstinence in rats.
    Kruszewska A
    Drug Alcohol Depend; 1988 Feb; 21(1):37-41. PubMed ID: 3366053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: involvement of amygdaloid and thalamic structures.
    van der Laan JW; Bruinvels J
    Brain Res; 1981 Dec; 229(1):133-46. PubMed ID: 6272932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the pharmacology of inhibitors of GABA-metabolism.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):119-28. PubMed ID: 6782493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: suppression by alpha 2-adrenoceptor stimulation.
    van der Laan JW; Weick G; Hillen FC
    Psychopharmacology (Berl); 1983; 81(3):267-71. PubMed ID: 6139840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo.
    Iadarola MJ; Gale K
    Eur J Pharmacol; 1979 Oct; 59(1-2):125-9. PubMed ID: 389641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
    Neal MJ; Shah MA
    Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of branched-chain fatty acids on GABA-degradation and behavior: further evidence for a role of GABA in quasi-morphine abstinence behavior.
    van der Laan JW; Jacobs AW; Bruinvels J
    Pharmacol Biochem Behav; 1980 Dec; 13(6):843-9. PubMed ID: 6782587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus.
    Qume M; Fowler LJ
    Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain.
    Cubells JF; Blanchard JS; Smith DM; Makman MH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):508-14. PubMed ID: 3735130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline.
    de Boer T; Metselaar HJ; Bruinvels J
    Life Sci; 1977 Mar; 20(6):933-41. PubMed ID: 191711
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of GABA-ergic substances on the analgesic effect of morphine in rats].
    Ostrovskaia RU; Bulaev VM
    Biull Eksp Biol Med; 1979 Jul; 88(7):35-7. PubMed ID: 380685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats.
    Sayin U; Atasoy S; Uzbay IT; Aricioğlu-Kartal F; Koyuncuoğlu H
    Pharmacol Res; 1998 Jul; 38(1):45-51. PubMed ID: 9697154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate.
    Noble EP; Gillies R; Vigran R; Mandel P
    Psychopharmacologia; 1976 Mar; 46(2):127-31. PubMed ID: 781711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate prevents the induction, but not the expression of morphine sensitization in mice.
    Li JX; Zhang Q; Liang JH
    Behav Brain Res; 2004 Jul; 152(2):251-7. PubMed ID: 15196792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.